首页> 外文期刊>Journal of enzyme inhibition and medicinal chemistry. >Design, synthesis and pharmacological evaluation of conformationally restricted N-arylsulfonyl-3-aminoalkoxy indoles as a potential 5-HT6 receptor ligands.
【24h】

Design, synthesis and pharmacological evaluation of conformationally restricted N-arylsulfonyl-3-aminoalkoxy indoles as a potential 5-HT6 receptor ligands.

机译:设计,合成和药理学评估构象受限的N-芳基磺酰基-3-氨基烷氧基吲哚作为潜在的5-HT6受体配体。

获取原文
获取原文并翻译 | 示例
           

摘要

A series of novel conformationally restricted N(1)-arylsulfonyl-3-aminoalkoxy indoles were designed and synthesized as 5-HT(6) receptor (5-HT(6)R) ligands. Many of the synthesized compounds have moderate in vitro-binding affinities at 5-HT(6)R. The lead compound 8b (% inhibition = 97.2 at 1 muM) from this series has good pharmacokinetic profile in male Wister rats and is active in animal model of cognition like Morris water maze. The details of chemistry, SAR, pharmacokinetics and pharmacological data constitute the subject matter of this report.
机译:一系列新型构象受限的N(1)-芳基磺酰基-3-氨基烷氧基吲哚被设计并合成为5-HT(6)受体(5-HT(6)R)配体。许多合成的化合物在5-HT(6)R具有中等的体外结合亲和力。该系列的先导化合物8b(1μM时抑制%= 97.2)在雄性Wister大鼠中具有良好的药代动力学特征,并且在认知动物模型(如莫里斯水迷宫)中具有活性。化学,SAR,药代动力学和药理学数据的细节构成本报告的主题。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号